Sanofi says sees "strong strategic" fit with U.S. cancer firm Medivation

PARIS, May 4 (Reuters) - Sanofi sees a strong strategic fit with U.S. cancer drug maker Medivation, the French pharmaceuticals company's chief executive said on Wednesday after recently approaching the company about a tie-up.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.